Literature DB >> 25483986

α-dystroglycan is a potential target of matrix metalloproteinase MMP-2.

Diego Sbardella1, Francesca Sciandra2, Magda Gioia1, Stefano Marini1, Alessandro Gori3, Bruno Giardina4, Umberto Tarantino1, Massimo Coletta1, Andrea Brancaccio2, Manuela Bozzi5.   

Abstract

Dystroglycan (DG) is a member of the glycoprotein complex associated to dystrophin and composed by two subunits, the β-DG, a transmembrane protein, and the α-DG, an extensively glycosylated extracellular protein. The β-DG ectodomain degradation by the matrix metallo-proteinases (i.e., MMP-2 and MMP-9) in both, pathological and physiological conditions, has been characterized in detail in previous publications. Since the amounts of α-DG and β-DG at the cell surface decrease when gelatinases are up-regulated, we investigated the degradation of α-DG subunit by MMP-2. Present data show, for the first time, that the proteolysis of α-DG indeed occurs on a native glycosylated molecule enriched from rabbit skeletal muscle. In order to characterize the α-DG portion, which is more prone to cleavage by MMP-2, we performed different degradations on tailored recombinant domains of α-DG spanning the whole subunit. The overall bulk of results casts light on a relevant susceptibility of the α-DG to MMP-2 degradation with particular reference to its C-terminal domain, thus opening a new scenario on the role of gelatinases (in particular of MMP-2) in the degradation of this glycoprotein complex, taking place in the course of pathological processes.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Dystroglycan; MMP-2; Metalloproteinase

Mesh:

Substances:

Year:  2014        PMID: 25483986     DOI: 10.1016/j.matbio.2014.11.007

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  5 in total

Review 1.  Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles.

Authors:  Hala S Alameddine; Jennifer E Morgan
Journal:  J Neuromuscul Dis       Date:  2016-11-29

2.  The enzymatic processing of α-dystroglycan by MMP-2 is controlled by two anchoring sites distinct from the active site.

Authors:  Magda Gioia; Giovanni Francesco Fasciglione; Diego Sbardella; Francesca Sciandra; MariaLuisa Casella; Serena Camerini; Marco Crescenzi; Alessandro Gori; Umberto Tarantino; Paola Cozza; Andrea Brancaccio; Massimo Coletta; Manuela Bozzi
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

Review 3.  Extracellular matrix: an important regulator of cell functions and skeletal muscle development.

Authors:  Weiya Zhang; Yuan Liu; Hong Zhang
Journal:  Cell Biosci       Date:  2021-03-31       Impact factor: 7.133

4.  Shrinkage Properties and Their Relationship with Degradation of Proteins Linking the Endomysium and Myofibril in Lamb Meat Submitted to Heating or Air Drying.

Authors:  Weili Rao; Zhenxiao Shi; Sijia Liu; Ying Shu; Xiaoyu Chai; Zhisheng Zhang
Journal:  Foods       Date:  2022-07-27

Review 5.  A molecular overview of the primary dystroglycanopathies.

Authors:  Andrea Brancaccio
Journal:  J Cell Mol Med       Date:  2019-03-05       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.